← Back to Search

Biological

Autocontrolled Arm for Male Pattern Baldness

Phase 1 & 2
Waitlist Available
Led By Maryanne M. Senna, MD
Research Sponsored by Santiste Medical Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 and month 8
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of two different types of platelet-rich plasma (PRP) on male patients with androgenic alopecia (AGA). One type of PRP will be activated with pulsed electrical fields (PEFA-PRP), while the other will not be activated (non-activated PRP). The trial will assess the clinical benefit of PEFA-PRP versus non-activated PRP treatment.

Eligible Conditions
  • Male Pattern Baldness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 and month 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 and month 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in hair density and hair regrowth
Measurement of hair regrowth
Secondary study objectives
Clinical progression of treatment as determined by principal investigator
Clinical progression of treatment as determined by subject

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Autocontrolled ArmExperimental Treatment1 Intervention
The subject will be treated with both the experimental treatment and the active comparator.

Find a Location

Who is running the clinical trial?

Santiste Medical Inc.Lead Sponsor
Maryanne M. Senna, MDPrincipal InvestigatorLahey Hospital & Medical Center
~4 spots leftby Nov 2025